Ebselen

Ebselen is a organoselenium compound with anti-inflammatory, anti-oxidant and cytoprotective activity. Ebselen acts as a glutathione peroxidase mimetic and is thereby able to prevent cellular damage induced by reactive oxygen species (ROS). In addition, this agent inhibits the activity of a variety of enzymes including nitric oxide synthase (NOS), 5-lipoxygenase, cyclooxygenase, protein kinase C (PKC), NADPH oxidase and gastric H+/K+-ATPase. Furthermore, ebselen may be neuroprotective due to its ability to neutralize free radicals upon NMDA receptor activation thus, reducing lipoperoxidation mediated by glutamate-induced excitotoxicity. Ebselen is a poor inhibitor of AChE. Ebselen inhibited AChE activity with an IC50 of 29uM. Ebselen is an effective inhibitor of the Ag85 complex through covalent modification of a cysteine residue proximal to the Ag85 active site and is therefore a covalent, allosteric inhibitor

General

Type : Organoselenium,Thiol-reactive

Chemical_Nomenclature : 2-phenyl-1,2-benzoselenazol-3-one

Canonical SMILES : C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2

InChI : InChI=1S\/C13H9NOSe\/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10\/h1-9H

InChIKey : DYEFUKCXAQOFHX-UHFFFAOYSA-N

Other name(s) : 2-Phenyl-1,2-benzisoselenazol-3(2H)-one,Ebselene,Ebseleno,Ebselenum


MW : 274.17

Formula : C13H9NOSe

CAS_number : 60940-34-3

PubChem : 3194

UniChem : DYEFUKCXAQOFHX-UHFFFAOYSA-N

IUPHAR :

Wikipedia : Ebselen

Target

Families : Ebselen ligand of proteins in family: A85-Mycolyl-transferase

Stucture :

Protein : myctu-a85c

References (8)

Title : Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine-induced amnesia in mice - Martini_2018_J.Cell.Biochem_119_5598
Author(s) : Martini F , Pesarico AP , Bruning CA , Zeni G , Nogueira CW
Ref : Journal of Cellular Biochemistry , 119 :5598 , 2018
Abstract : Martini_2018_J.Cell.Biochem_119_5598
ESTHER : Martini_2018_J.Cell.Biochem_119_5598
PubMedSearch : Martini_2018_J.Cell.Biochem_119_5598
PubMedID: 29405440

Title : Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and reversibility of inhibition - Martini_2015_Curr.Pharm.Des_21_920
Author(s) : Martini F , Bruning CA , Soares SM , Nogueira CW , Zeni G
Ref : Curr Pharm Des , 21 :920 , 2015
Abstract : Martini_2015_Curr.Pharm.Des_21_920
ESTHER : Martini_2015_Curr.Pharm.Des_21_920
PubMedSearch : Martini_2015_Curr.Pharm.Des_21_920
PubMedID: 25312723

Title : Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease - Luo_2014_Bioorg.Med.Chem_22_1355
Author(s) : Luo Z , Liang L , Sheng J , Pang Y , Li J , Huang L , Li X
Ref : Bioorganic & Medicinal Chemistry , 22 :1355 , 2014
Abstract : Luo_2014_Bioorg.Med.Chem_22_1355
ESTHER : Luo_2014_Bioorg.Med.Chem_22_1355
PubMedSearch : Luo_2014_Bioorg.Med.Chem_22_1355
PubMedID: 24461494

Title : Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer's Disease Based on the Fusion of Donepezil and Ebselen - Luo_2013_J.Med.Chem_56_9089
Author(s) : Luo Z , Sheng J , Sun Y , Lu C , Yan J , Liu A , Luo HB , Huang L , Li X
Ref : Journal of Medicinal Chemistry , 56 :9089 , 2013
Abstract : Luo_2013_J.Med.Chem_56_9089
ESTHER : Luo_2013_J.Med.Chem_56_9089
PubMedSearch : Luo_2013_J.Med.Chem_56_9089
PubMedID: 24160297

Title : Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity - Mao_2013_Bioorg.Med.Chem.Lett_23_6737
Author(s) : Mao F , Chen J , Zhou Q , Luo Z , Huang L , Li X
Ref : Bioorganic & Medicinal Chemistry Lett , 23 :6737 , 2013
Abstract : Mao_2013_Bioorg.Med.Chem.Lett_23_6737
ESTHER : Mao_2013_Bioorg.Med.Chem.Lett_23_6737
PubMedSearch : Mao_2013_Bioorg.Med.Chem.Lett_23_6737
PubMedID: 24220172

Title : Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen - Favrot_2013_Nat.Commun_4_2748
Author(s) : Favrot L , Grzegorzewicz AE , Lajiness DH , Marvin RK , Boucau J , Isailovic D , Jackson M , Ronning DR
Ref : Nat Commun , 4 :2748 , 2013
Abstract : Favrot_2013_Nat.Commun_4_2748
ESTHER : Favrot_2013_Nat.Commun_4_2748
PubMedSearch : Favrot_2013_Nat.Commun_4_2748
PubMedID: 24193546
Gene_locus related to this paper: myctu-a85c

Title : Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents - Mazzanti_2009_Int.J.Dev.Neurosci_27_73
Author(s) : Mazzanti CM , Spanevello R , Ahmed M , Pereira LB , Goncalves JF , Correa M , Schmatz R , Stefanello N , Leal DB , Mazzanti A , Ramos AT , Martins TB , Danesi CC , Graca DL , Morsch VM , Schetinger MR
Ref : Int J Developmental Neuroscience , 27 :73 , 2009
Abstract : Mazzanti_2009_Int.J.Dev.Neurosci_27_73
ESTHER : Mazzanti_2009_Int.J.Dev.Neurosci_27_73
PubMedSearch : Mazzanti_2009_Int.J.Dev.Neurosci_27_73
PubMedID: 18930802

Title : The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site - Herin_2001_J.Neurochem_78_1307
Author(s) : Herin GA , Du S , Aizenman E
Ref : Journal of Neurochemistry , 78 :1307 , 2001
Abstract : Herin_2001_J.Neurochem_78_1307
ESTHER : Herin_2001_J.Neurochem_78_1307
PubMedSearch : Herin_2001_J.Neurochem_78_1307
PubMedID: 11579139